Oxymorphone controlled release formulations

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/485 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01) A61P 25/04 (2006.01)

Patent

CA 2452871

The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief.

L'invention concerne une méthode de soulagement de la douleur par administration d'un comprimé pharmaceutique à libération contrôlée contenant de l'oxymorphone produisant un niveau minimum dans le plasma sanguin 12 à 24 heures après la posologie ; l'invention concerne aussi le comprimé produisant un soulagement continu de la douleur.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oxymorphone controlled release formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oxymorphone controlled release formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxymorphone controlled release formulations will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1381874

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.